Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Big Names & Fresh Faces Headline Rogers Sports & Media’s Canadian Originals Slate for HGTV and Food Network
-
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic
-
Plum Wins Gold at the 5th Annual 2025 Globee® Awards for Disruptors
-
NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-291 in Spinal Cord Injury
-
Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass
-
Coda Octopus Group Sets Fiscal Second Quarter 2025 Earnings Conference Call for Monday, June 16, 2025, at 10 a.m. Eastern Time
-
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
-
Aura Minerals Agrees to Acquire the Mineração Serra Grande Gold Mine in Goiás, Brazil
-
ConnectOne Bancorp, Inc. Completes Merger With the First of Long Island Corporation
-
Vanguard Food LP Announces Closing of Transaction to Create Emerging Leader in North American Produce Industry
-
Village Farms International Announces Closing of Transaction to Privatize its Fresh Produce Business
-
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
-
Nokia and Andorix partner to accelerate Private 5G and Edge Solutions in North American real estate market
-
Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
-
Denodo University Challenge Now Open: Data and AI for Real-World Impact
-
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
-
Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
-
CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025
-
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
-
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
-
Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading Conference
-
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
-
Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
-
SAIC Announces First Quarter of Fiscal Year 2026 Results
-
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
-
Net Asset Value(s)
-
Patagonia Gold Announces Completion of US$40 Million Investment Into Its Calcatreu Project
-
Codere Online Announces Filing of 2024 Annual Report on Form 20-F
-
Castellum, Inc. to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd – Thursday,
-
Brazil Potash Year to Date Summary: Company Achieves Milestones, Advancing Strategic Autazes Project Further Towards Construction
-
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
-
Hyperscale Data Reports $219 Million in Assets at End of Q1 2025, Sells Minority Stake in Private Pharmaceutical Company for $4.65 Million as Part of Company Streamlining
-
First Atlantic Nickel to Attend Benchmark Mineral Intelligence's GIGA USA 2025 Conference, Highlighting Atlantic Nickel Project’s Smelter-Free Processing for North America’s Critical Minerals
-
First Atlantic Nickel to Attend Benchmark Mineral Intelligence's GIGA USA 2025 Conference, Highlighting Atlantic Nickel Project’s Smelter-Free Processing for North America’s Critical Minerals Supp
-
Vera Therapeutics Announces Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial in Adults with IgA Nephropathy
-
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
-
Piedmont REIT Signs over 500,000 SF of Leases Second Quarter-to-Date and Raises Full Year Leasing Guidance from 1.4 - 1.6 million SF to 1.8 - 2.0 million SF
-
Stomp Into Some Prehistoric Learning! Lingokids and BBC Earth Launch New Walking With Dinosaurs Lesson to Bring a Love of Dinosaurs to a New Generation
-
GFG Announces Encouraging Phase 1 Drill Results from Pen Gold Project, Ontario
-
ClarityCut AI Launches to Revolutionize Video Editing with AI-Powered Simplicity
-
Form 8.5 (EPT/RI) - Inspired Plc
-
BranchOut Food Inc. Announces Plan to Eliminate Current Liability Notes Payable with $1 Million Warrant Exercise and Extension of Key Financing Agreements
-
Form 8.5 (EPT/RI) - H&T Group Plc
-
Xilio Therapeutics Announces Proposed Public Offering
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Notice of extraordinary general meeting.
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Fortis Inc. Announces Results of Series H First Preference Share and Series I Preference Share Conversions
-
Radware Expands its Threat Intelligence Services
-
Cenovus Energy announces redemption of Series 7 Preferred Shares
